Cell Fate Conversion By mRNA

mRNA-based technology is being studied as a potential technology that could be used to reprogram cell fate. This technique provides the potential to generate safe reprogrammed cells that can be used for clinical applications. Here is the latest research on cell fate conversion by mRNA.

February 25, 2021
Open Access

Subcellular Architecture of the xyl Gene Expression Flow of the TOL Catabolic Plasmid of Pseudomonas putida mt-2.

MBio
Juhyun KimVíctor de Lorenzo
February 25, 2021
Open Access

Single-cell multiomics sequencing reveals the functional regulatory landscape of early embryos.

Nature Communications
Yang WangLiying Yan
February 25, 2021

Deep clinical phenotyping and gene expression analysis in a patient with RCBTB1-associated retinopathy.

Ophthalmic Genetics
Zhiqin HuangFred K Chen
February 24, 2021
Open Access

Tricks and threats of RNA viruses - towards understanding the fate of viral RNA.

RNA Biology
Lukasz MarkiewiczPawel J Sikorski
February 24, 2021
Open Access

Three-dimensional model of glioblastoma by co-culturing tumor stem cells with human brain organoids.

Biology Open
Roberta AzzarelliBenjamin D Simons
February 24, 2021
Review

Direct cell reprogramming: approaches, mechanisms and progress.

Nature Reviews. Molecular Cell Biology
Haofei WangLi Qian
February 24, 2021

Variability within rare cell states enables multiple paths toward drug resistance.

Nature Biotechnology
Benjamin L EmertArjun Raj
February 24, 2021
Open Access

Protein products of nonstop mRNA disrupt nucleolar homeostasis.

Cell Stress & Chaperones
Zoe H DavisOnn Brandman
February 24, 2021

Single-Cell RNA Sequencing Analysis of the Drosophila Larval Ventral Cord.

Current Protocols
Tho Huu NguyenMihaela Serpe
February 24, 2021

Single-cell RNA sequencing of preadipocytes reveal the cell fate heterogeneity induced by melatonin.

Journal of Pineal Research
Zhenhui LiQinghua Nie
February 23, 2021
Open Access

Direct Evidence of Abortive Lytic Infection-Mediated Establishment of Epstein-Barr Virus Latency During B-Cell Infection.

Frontiers in Microbiology
Tomoki InagakiHiroshi Kimura
February 23, 2021
Open Access

Alzheimer's Risk Gene TREM2 Determines Functional Properties of New Type of Human iPSC-Derived Microglia.

Frontiers in Immunology
Marvin ReichMarkus Britschgi
February 23, 2021

Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholangiocarcinoma cells.

European Journal of Pharmacology
Tawit SuriyoJutamaad Satayavivad
February 19, 2021

USP22 deficiency in melanoma mediates resistance to T-cell through IFNγ-JAK1-STAT1 signal axis.

Molecular Therapy : the Journal of the American Society of Gene Therapy
Min LiXuanming Yang
February 20, 2021
Open Access

Emergence of diauxie as an optimal growth strategy under resource allocation constraints in cellular metabolism.

Proceedings of the National Academy of Sciences of the United States of America
Pierre Salvy, Vassily Hatzimanikatis
February 20, 2021
Review
Open Access

Improvements in Gene Editing Technology Boost Its Applications in Livestock.

Frontiers in Genetics
Iuri Viotti PerisseIrina A Polejaeva

Sign up to follow this feed and discover related papers.

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Autoimmune Disease Therapy

In autoimmune diseases, the immune system responds and attacks self-antigens and damages or impairs the function of the tissues. The treatment for autoimmune diseases often involves immunosuppressive agents, but newer treatments are being investigated. Discover the latest research on autoimmune disease therapy here.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Cardiac Regeneration

Cardiac regeneration enables the repair of irreversibly damaged heart tissue using cutting-edge science, including stem cell and cell-free therapy. Discover the latest research on cardiac regeneration here.

Chromatin Regulators: Differentiation

Chromatin regulators affect gene expression by influencing the access of proteins such as transcription factors to DNA. Here is the latest research on the role of chromatin regulating proteins on cellular differentiation.

Ciliary Signaling & Growth

Cilia produce different signaling molecules including ciliary neurotrophic factor that modulate the expression of many processes throughout the body. Exploiting the signaling pathway may be a therapeutic strategy for promoting the growth of different cell types. Here is the latest research on ciliary signaling and growth.

Cis & Trans Regulatory Elements

Cis-regulatory elements are regions DNA that regulate the transcription of neighbouring genes. Trans-regulatory elements are genomic loci that regulate the expression of distant genes. Here is the latest research on CREs and TREs.

Craniofacial Stem Cells

Human craniofacial stem cells are recently discovered sources of putative mesenchymal stem cells that hold great promise for autogenic or allogenic cell therapy and tissue engineering. Here is the latest research.

© 2021 Meta ULC. All rights reserved
/feed-previews/cell-fate-conversion-by-mrna/af3d6cd3-e97f-42af-b1b2-500bea6138a6